Madrigal Pharmaceuticals (MDGL) Times Interest Earned (2010 - 2026)
Madrigal Pharmaceuticals' (MDGL) quarterly Times Interest Earned came in at -$11.86 in Q1 2026, up 50.7% year-on-year from -$7.87 in Q1 2025, and down 2323.62% on a QoQ basis from -$0.49 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Times Interest Earned (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 16 years of Times Interest Earned data on file, last reported at -$11.86 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 50.7% year-over-year to -$11.86 in Q1 2026; TTM through Mar 2026 was -$2.23, a 99.71% increase from a year earlier, with the FY2025 full-year figure at -$0.51, up 48.11% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$11.86, down from -$0.49 in the prior quarter.
- Over the last five years, Times Interest Earned for MDGL reached as high as $6.65 in Q4 2024 and fell as low as -$90.09 in Q2 2022.
- Historically, Times Interest Earned has averaged -$30.66 across 5 years, with a median of -$29.65 in 2023.
- Across the five-year window, Times Interest Earned jumped 122.54% in 2024 and plunged 107.36% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$50.71 in 2022, then surged by 41.81% to -$29.51 in 2023, then soared by 122.54% to $6.65 in 2024, then slumped by 107.36% to -$0.49 in 2025, then plunged by 2323.62% to -$11.86 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$11.86 in Q1 2026, -$0.49 in Q4 2025, and -$15.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Madrigal Pharmaceuticals | 15.79 Bn | 15.56 Bn | - | -11.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.86 |
| Dec 31, 2025 | -0.49 |
| Sep 30, 2025 | -15.30 |
| Jun 30, 2025 | -14.46 |
| Mar 31, 2025 | -24.06 |
| Dec 31, 2024 | 6.65 |
| Sep 30, 2024 | -31.61 |
| Jun 30, 2024 | -44.46 |
| Mar 31, 2024 | -39.61 |
| Dec 31, 2023 | -29.51 |
| Sep 30, 2023 | -28.12 |
| Jun 30, 2023 | -29.80 |
| Mar 31, 2023 | -33.53 |
| Dec 31, 2022 | -50.71 |
| Sep 30, 2022 | -53.54 |
| Jun 30, 2022 | -90.09 |
| Dec 31, 2020 | -0.45 |
| Sep 30, 2020 | -3,919.07 |
| Jun 30, 2020 | -25,163.50 |
| Mar 31, 2020 | -883.84 |